About REXAHN

Rexahn Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to developing the next generation of targeted therapeutics for the treatment of cancer.
Rexahn's clinical development programs target specific proteins that are selectively localized in human cancer cells and not in healthy tissues resulting in increased efficacy and reduced toxicity.


News

Rexahn Pharmaceuticals to Present at the 17th Annual Rodman and Renshaw Global Investment Conference on September 10, 2015


Rexahn Pharmaceuticals Reports Second Quarter 2015 Financial Results and Provides Corporate Update


More


Portfolio